Sign in

CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
460920988
Phone
805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. DEFR14A Other DEFR14A
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. DEFA14A Proxy Proxy Materials
  8. DEF 14A Proxy Proxy Statement
  9. PRE 14A Proxy Proxy Statement (Preliminary)
  10. 4 Grant or award Director acquired 150,000 shares (grant or award)
  11. 4 Grant or award Director acquired 150,000 shares (grant or award)
  12. 4 Grant or award Director acquired 150,000 shares (grant or award)
  13. 4 Grant or award Director acquired 150,000 shares (grant or award)
  14. 4 Grant or award Director acquired 150,000 shares (grant or award)
  15. 8-K Event Executive or director change
  16. 10-K Report Annual Report
  17. 8-K Event Results of operations
  18. SC 13G Stake Amended Statement of Ownership
  19. 4 Open-market sale President and CEO sold 24,844 shares at $0.72 ($17,888)
  20. 4 Open-market sale EVP, Chief Sci. & Tech Officer sold 10,746 shares at $0.72 ($7,737)

Page 10 of 57 · 1,133 filings